Gapping down
In reaction to earnings/guidance:
- ZTO -6.2%, GEVO -5.8%, PD -5.1%, RIDE -4.6% (also says timeline to start production remains on track for Sept 2021), DG -4.5%, MLHR -3.3%, TITN -1.6%, UTZ -1.4%
Other news:
- TBIO -26.5% (reports clinical trial results for MRT5005)
- PHAS -13.9% (prices offering of 16 mln shares of common stock at $3.50 per share)
- CFRX -12.2% (prices offering of 10 mln shares of common stock at $5.00 per share)
- SLDB -4.7% (stock offering)
- AHT -3.9% (stock offering)
- MAXR -3.7% (prices $400 mln common stock offering)
- NOK -3.3% (Capital Markets update)
- PAYA -3% (prices offering of 20 mln shares of common stock at $12.25 per share)
- IIVI -2.6% (Coherent confirms receipt of revised proposal from IIVI)
- U -2.5% (new CFO)
- SHC -2.3% (prices 25 mln shares of common stock at $27.00 per share)
- PENN -1.2% (to launch Barstool Sportsbook app in VA in coming months)
- PANW -1.1% (new CFO)
Analyst comments:
- ADNT -2.6% (downgraded to Underweight from Equal-Weight at Morgan Stanley)
- PDD -2.3% (downgraded to Hold from Buy at Truist)
- FTI -1.8% (downgraded to Neutral from Buy at Citigroup)
- KRP -1.4% (downgraded to Equal Weight from Overweight at Wells Fargo)
- CLX -1.1% (downgraded to Neutral from Buy at DA Davidson)